CDK2 and cancer: In marked contrast to the actions of pharmacologic or genetically mediated repression of CDK2 activity in aneuploid cancer cells, normal human alveolar epithelial cells (HAEC) proved resistant to the growth inhibitory or proapoptotic effects of this inhibition (21).